Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Science In Sport Plc LSE:SIS London Ordinary Share GB00BBPV5329 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00 -1.23% 80.00 52,490 15:46:46
Bid Price Offer Price High Price Low Price Open Price
78.00 82.00 81.00 80.00 81.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Leisure Goods 50.35 -2.77 -1.30 108
Last Trade Time Trade Type Trade Size Trade Price Currency
15:48:42 O 8,203 80.15 GBX

Science In Sport (SIS) Latest News (1)

More Science In Sport News
Science In Sport Investors    Science In Sport Takeover Rumours

Science In Sport (SIS) Discussions and Chat

Science In Sport Forums and Chat

Date Time Title Posts
11/6/202113:16Science in Sport420
04/3/201819:06Man U Sponsorship-
12/1/200421:16On The Right Track CybIT-
12/1/200421:15On The Right Track-

Add a New Thread

Science In Sport (SIS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-06-24 14:48:4380.158,2036,574.70O
2021-06-24 14:46:4778.00243189.54O
2021-06-24 14:46:4782.0021.64O
2021-06-24 14:46:4778.0010.78O
2021-06-24 14:46:4782.00119.02O
View all Science In Sport trades in real-time

Science In Sport (SIS) Top Chat Posts

DateSubject
24/6/2021
09:20
Science In Sport Daily Update: Science In Sport Plc is listed in the Leisure Goods sector of the London Stock Exchange with ticker SIS. The last closing price for Science In Sport was 81p.
Science In Sport Plc has a 4 week average price of 78.50p and a 12 week average price of 60p.
The 1 year high share price is 84p while the 1 year low share price is currently 28.50p.
There are currently 135,100,931 shares in issue and the average daily traded volume is 122,906 shares. The market capitalisation of Science In Sport Plc is £108,080,744.80.
11/6/2021
13:16
bareknee: Re "Hands up if you lobbed too early" Guilty as charged ! Having, for once, bought in at the right time at ~31p, I sold a third of my holding at ~60p and sold the second third at ~81p. If the price keeps rising, without any major positive news, then I see 100p+ as a total exit point. If SiS gets taken out, then my strategy will look a bit foolish ! Incidentally, Brighter Foods was bought on ~2x revenue and was turning a decent profit, though Grenade did go for a bigger premium of 4x revenue on very little profit. They're similar companies to SiS, so comparisons are valid, but, though a similar size, SiS feels a bit more niche ? The stated target here is roughly double digit EBITDA returns on revenues of ~100 million, so EBIDTA of ~10 million [n] years down the line. At 81p, we currently have a market cap of ~110 million, so, though we're not hideously overvalued, I do think we're very much on the top side of fair value.
10/6/2021
16:15
sphere25: Blooming hek, it's still going up. Hands up if you lobbed too early, including quicker trades? So err...yeah :-) Haven't tried the hydration tabs (maybe they help with trading?) Oiht but did try one of the SIS Isotonic gel's a while back. It made me want to punch myself in the face....repeatedly. Yuk! Horrible taste so that needs improving. The protein shakes are good though. Anyway here is River and Mercantile highlighting how erm.. "cheap" SIS is: "The most significant contributor to performance in the month was Science in Sport, our largest holding, which finished the month 19% higher. It appears that corporate activity in the sector may be behind the re-rating with The Hut Group acquiring Brighter Foods and Mondelez acquiring Grenade (a reported 4x EV/Sales which compares nicely to SIS’ multiple of sales of less than 2x). " All imo DYOR
09/6/2021
18:08
oiht: I buy SIS hydration tabs, I've tried other brands but somehow I always come back to SIS despite the premium price. I am a holder of the shares though, so I readily concede that I am not impartial. I took up my full entitlement of rights issue in 2107 and now, for the first time in years, I am actually 'in the money' by fourteen quid. Yeeha!! Only today I ordered three more tubes of berry flavour - that should hit the bottom line any day :-o
15/4/2021
12:34
sphere25: Some interesting numbers from THG on the Nutrition front. I have tried some of their products, it is all discount based with one discount often mounted on top of another to make the whole product appeal alot more and look great value in the market. I doubt any regular buyer of MyProtein products now buys without a bundle of discounts, it is more the cheap and cheerful product in the market. SIS product is better in my opinion. THG report significant growth in new customer numbers with the number of orders +41% for Nutrition. Interesting sequence of numbers: H1 2020 +30.5% Q3 2020 145.4m +42.8% Q3 2019 101.8m Q4 2020 158.2m +39.6% Q4 2019 113.4m FY 2020 562.3m +36.2% FY 2019 412.9m Q1 2021 146.3m +32.1% YOY but -7.5% QOQ Q1 2020 110.8m Is the online lockdown benefit waning and how will that feed through to SIS? THG are are still making really bullish noises with a whopping amount of new product launches: "As consumers seek healthier lifestyles, THG Nutrition's brand family is innovating to meet growing demand, through the launch of over two hundred new products with a focus on convenience, sustainability and education" Very short report, was scrolling down looking for the rest of it :-) THG currently -5%. Even though I'm not as financially interested in SIS now beyond these shorter term trades, still interested to see how the story pans out here and whether the seemingly premium valuation turns out to be not so "seemingly premium". All imo DYOR
17/3/2021
15:30
sphere25: Further to the previous post, this is a case in point on valuations and perceptions of valuations. If somebody did a survey to look at those results and ask the question on whether the shares represented value, would the majority of participants say it represented value? Personally speaking, I wouldn't put this in the value basket. However, in these markets, premiums are willing to be paid and those who ride the waves regardless of valuations have clearly been doing the best. I have been lobbing here because it has gone through what I thought was a bullish target price but the market is more than happy to continue bidding the shares up. When I lob, prices usually keep going higher - that's my new party trick and the market. On the flip side, why could the market be willing to pay a premium valuation here? Naturally there is the resilient revenue performance which the market believes is the foundation for further growth as lockdowns ease/end. There is also margin improvement and the growth in online sales has been good. The online growth has also accelerated into the new financial year and the market clearly believes the online side will be more resilient even when high streets open up. There must also be a belief in the international growth, particularly the likes of the US where SIS have alighted to 33% revenue growth and significantly reduced cash burn gain more traction. Furthermore, the market opportunity is clearly growing and there must be alot of pent up demand from folk who want to get out and exercise more freely and perhaps more who are being advised to get out and exercise more on health grounds from being inside all the time. Clearly people want to get out and live their lives more so perhaps there will be greater focus on the health side as a result of the pandemic. Headlines like the one today that Brits will go on a £50 billion spending spree have been adding to the optimism in all markets. Naturally, there is a divide here with lower income folk not being in as strong a position to save, or indeed not save altogether, with so much commentary on savings increasing. SIS have also delayed product launches so some of that must be feeding into the valuation too. I have tried numerous PHD products and they are good. They are clean, taste good and have worked well for me. The range of flavours is extensive with the likes of chocolate mint though haven't tried the Raspberry and White choc or Cherry Bakewell! The pricing can be more premium, but offers are regular, so you can pick them up buy one get one free at times - Holland and Barrett do the offers. Clearly it is all about execution now and SIS is priced for solid execution. Even though many can argue the sales metrics are cheap relative to wider markets, there cannot be slip ups in my humble opinion. Happy to keep an eye on it though do tend to lose interest in the ones that have hit targets beyond quick trades. All imo DYOR
17/3/2021
12:22
energeticbacker: The shares have climbed 78% since Investor's Champion's previous commentary in December 2020 (share price 31.3p) with the the market capitalisation now c£76m. While that does not look excessive for a company generating annual sales of c£50m, those sales have only been achieved after a huge spend on marketing and it has yet to demonstrate an ability to actually make money. More on Investor's Champion's website.
15/3/2021
12:39
sphere25: Price currently 52p. Finally gone through the price target and gap close on the chart. It looks like the offer has been pulled ahead of the results here by the sellers who were holding this back for a while. It is not unknown for this to happen. They will reassess on the results due this week on the 17th March. Happy to have ridden this one along with a nice market that has afforded everyone (particularly short term folk) the luxury of giving shares more of a chance. If the market wasn't as bullish or less stable, then the approach would clearly be different with less leeway given, and indeed immediate cuts for anything that didn't work if it was very volatile. Part of the interest with SIS was the statements taking a more bullish tone (sometimes indicative of a major turn with recovery potential) but also the wider premium ratings that the market has been willing to pay, so despite understandable skepticism by some posters on SIS (as well as my usual ramblings on overvalued parts of the market), it almost doesn't matter about our perception of a valuation at times. What can matter more is our perception of the market's perception of the value, which is all related to the level of bullish spirits. Working on operating metrics of sales with the likes of SIS isn't really my thing, but clearly there are arguments both ways for value here and the market has been happy to bid it up i.e. very bullish spirits and a belief that the future has changed for the better for SIS. Happy to ride these waves in many companies, and selling along the way, but not one to get attached to any company. Hard to say how the market will react to the update here on Wednesday. With the more premium type of rating, the outlook will have to be a positively solid in line with expectations statement at worst imo. Clearly different for longer term folk. Onwards! All imo DYOR
11/2/2021
11:44
sphere25: Recent note: "Liberum: SIS shares remain cheap Science in Sport (SIS) has put the building blocks in place to deliver growth and its shares remain cheap, says Liberum. Analyst Adam Tomlinson retained his ‘buy’ recommendation and target price of 80p on the sports drinks company, which closed up 2.3%, or 1p, at 45p yesterday. After a ‘resilient full year 2020’ and a positive capital markets presentation, ‘the building blocks are now in place for SIS to deliver long-term profitable growth’, Tomlinson said. ‘Management217;s confidence in returning to pre-Covid-19 top-line growth rates was clear and this has set the basis for new medium-term targets of £100m of sales…,’ he said. Tomlinson added that margin expansion will be supported by ‘supply chain consolidation and leveraging the well-invested cost base’ and that the shares remain cheap on a current year 2021 embedded value/sales [multiple] of 1 times versus peers on 2 times." Again as per posts today on broker calls, it's all too bullish. Also don't like it when we have to talk about valuations in operating metrics based on sales rather profits and cashflow so perhaps pushing the boat out here more than usual. The thing is though, that is the kind of market we are in! The valuations aren't giving any guide to future performance and what appears to be expensive has continued to go higher and become more expensive. Folk will have noted alot of my terrible selling based on what I have thought was a fairer value after realising good gains in alot of highlighted shares, except the near majority of those have carried on going higher so it really has been one of those markets that continues to surprise. Furthermore, the US appears even more bullish than the analyst above. If SIS was offered to US investors, they'd look at that operating metric of 1 and double it and more in a flash so you'd probably end up smashing through the 80p target in one fair swoop. The path of least resistance continues to be up regardless of views on valuation. Looks like we've got stuck here atm but more bullish updates and the re-rates in the likes of SIS will continue. If something changes for the worse at some point in the future, then clearly have to give back some of the gains. All imo DYOR
15/1/2021
19:16
thirty fifty twenty: hi lammylover of course your points are all reasonably correct, are you a holder? my strategy is to look forward, and assess the risk reward on that basis. as a starting point they have grown a business to 50m of sales. that business is in a growth area, and has remained steady during the pandemic - so it has something going for it. they talk of 100m sales - in which case that would be an acheivement from scratch for a business yes in the past they have raised funds but say no more will be needed, that makes sense given the business is now getting some scale, but appreciate the proof is also in the pudding. in 2014 sales were 6.5m and 25m shares in issue i.e. there was c.25p revenue per share - the business was loss-making in 2020 sales were 50m on 125m shares i.e. there was c.40p revenue per share - the business is at small profit in the past people paid £1 a share for 25p of los making revenue today one can pay 40p for 40p of profitable revenue at a very simple level the business much better value now. will it succeed - i dont know. but if it does succeed the price could be much higher i am looking at long term risk/reward in particular the chart gives very good turnaround indications. time will tell All IMHO, DYOR + BoL SIS is in my portfolio
15/1/2021
17:34
lammylover: SIS background: - Not made a penny profit in 5 years - Not paid a penny out in dividends in 5 years - Share price halved in last 5 years - Keep coming back to share holders for fundraisers to prop up accounts - Regular 25-50% discount on products sold to help revenue keep growing - Board keep paying themselves hefty salaries and free shares based on revenue - More promises of jam tomorrow on a regular basis Discuss.....
Science In Sport share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
SIS
Science In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210625 04:21:53